1. MoumenM, ChicheA, CagnetS, PetitV, RaymondK, et al. (2011) The mammary myoepithelial cell. Int J Dev Biol 55: 763–771.
2. ForsterN, SaladiSV, van BragtM, SfondourisME, JonesFE, et al. (2014) Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1. Dev Cell 28: 147–160.
3. Van KeymeulenA, RochaAS, OussetM, BeckB, BouvencourtG, et al. (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature 479: 189–193.
4. RiosAC, FuNY, LindemanGJ, VisvaderJE (2014) In situ identification of bipotent stem cells in the mammary gland. Nature 506: 322–327.
5. ShackletonM, VaillantF, SimpsonKJ, StinglJ, SmythGK, et al. (2006) Generation of a functional mammary gland from a single stem cell. Nature 439: 84–88.
6. StinglJ, EirewP, RicketsonI, ShackletonM, VaillantF, et al. (2006) Purification and unique properties of mammary epithelial stem cells. Nature 439: 993–997.
7. SiegelPM, MullerWJ (2010) Transcription factor regulatory networks in mammary epithelial development and tumorigenesis. Oncogene 29: 2753–2759.
8. ZhengQ, ZhaoY (2007) The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction. Biol Cell 99: 489–502.
9. AgulnickAD, TairaM, BreenJJ, TanakaT, DawidIB, et al. (1996) Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature 384: 270–272.
10. BachI, CarriereC, OstendorffHP, AndersenB, RosenfeldMG (1997) A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins. Genes Dev 11: 1370–1380.
11. JurataLW, KennyDA, GillGN (1996) Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc Natl Acad Sci U S A 93: 11693–11698.
12. VisvaderJE, MaoX, FujiwaraY, HahmK, OrkinSH (1997) The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc Natl Acad Sci U S A 94: 13707–13712.
13. JurataLW, GillGN (1997) Functional analysis of the nuclear LIM domain interactor NLI. Mol Cell Biol 17: 5688–5698.
14. MatthewsJM, VisvaderJE (2003) LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins. EMBO Rep 4: 1132–1137.
15. DawidIB, BreenJJ, ToyamaR (1998) LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet 14: 156–162.
16. BachI (2000) The LIM domain: regulation by association. Mech Dev 91: 5–17.
17. SolerE, Andrieu-SolerC, de BoerE, BryneJC, ThongjueaS, et al. (2010) The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev 24: 277–289.
18. DengW, LeeJ, WangH, MillerJ, ReikA, et al. (2012) Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell 149: 1233–1244.
19. SongSH, KimA, RagoczyT, BenderMA, GroudineM, et al. (2010) Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation. Blood 116: 2356–2364.
20. MukhopadhyayM, TeufelA, YamashitaT, AgulnickAD, ChenL, et al. (2003) Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation. Development 130: 495–505.
21. JohnsenSA, GüngörC, PrenzelT, RiethdorfS, RiethdorfL, et al. (2009) Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer. Cancer Res 69: 128–136.
22. XuX, MannikJ, KudryavtsevaE, LinKK, FlanaganLA, et al. (2007) Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells. Dev Biol 312: 484–500.
23. SunP, YuanY, LiA, LiB, DaiX (2010) Cytokeratin expression during mouse embryonic and early postnatal mammary gland development. Histochem Cell Biol 133: 213–221.
24. AryeeMJ, Gutiérrez-PabelloJA, KramnikI, MaitiT, QuackenbushJ (2009) An improved empirical bayes approach to estimating differential gene expression in microarray time-course data: BETR (Bayesian Estimation of Temporal Regulation). BMC Bioinformatics 10: 409.
25. BaiL, RohrschneiderLR (2010) s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev 24: 1882–1892.
26. PratA, PerouCM (2011) Deconstructing the molecular portraits of breast cancer. Mol Oncol 5: 5–23.
27. ParkerJS, MullinsM, CheangMC, LeungS, VoducD, et al. (2009) Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 27: 1160–1167.
28. van de VijverMJ, HeYD, van't VeerLJ, DaiH, HartAA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999–2009.
29. GuedjM, MarisaL, de ReyniesA, OrsettiB, SchiappaR, et al. (2012) A refined molecular taxonomy of breast cancer. Oncogene 31: 1196–1206.
30. MosleyJD, KeriRA (2008) Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Med Genomics 1: 11.
31. BaldiP, LongAD (2001) A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 17: 509–519.
32. SubramanianA, TamayoP, MoothaVK, MukherjeeS, EbertBL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.
33. PlaksV, BrenotA, LinnemannJR, WongKC, WerbZ (2013) Lgr5-Expressing Cells Are Sufficient and Necessary for Postnatal Mammary Gland Organogenesis. Cell Reports 3: 70–78.
34. LuP, EwaldAJ, MartinGR, WerbZ (2008) Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 321: 77–87.
35. ParsaS, RamasamySK, De LangheS, GupteVV, HaighJJ, et al. (2008) Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev Biol 317: 121–131.
36. Jackson-FisherAJ, BellingerG, BreindelJL, TavassoliFA, BoothCJ, et al. (2008) ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res 10: R96.
37. Jackson-FisherAJ, BellingerG, RamabhadranR, MorrisJK, LeeKF, et al. (2004) ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci U S A 101: 17138–17143.
38. Asselin-LabatML, SutherlandKD, BarkerH, ThomasR, ShackletonM, et al. (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201–209.
39. WangN, KudryavtsevaE, Ch'enIL, McCormickJ, SugiharaTM, et al. (2004) Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice. Oncogene 23: 1507–1513.
40. WangN, LinKK, LuZ, LamKS, NewtonR, et al. (2007) The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene 26: 6431–6441.
41. SumEY, ShackletonM, HahmK, ThomasRM, O'ReillyLA, et al. (2005) Loss of the LIM domain protein Lmo4 in the mammary gland during pregnancy impedes lobuloalveolar development. Oncogene 24: 4820–4828.
42. SumEY, SegaraD, DuscioB, BathML, FieldAS, et al. (2005) Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer. Proc Natl Acad Sci U S A 102: 7659–7664.
43. SugiharaTM, BachI, KioussiC, RosenfeldMG, AndersenB (1998) Mouse deformed epidermal autoregulatory factor 1 recruits a LIM domain factor, LMO-4, and CLIM coregulators. Proc Natl Acad Sci U S A 95: 15418–15423.
44. DeaneJE, RyanDP, SundeM, MaherMJ, GussJM, et al. (2004) Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex. Embo J 23: 3589–3598.
45. KennyDA, JurataLW, SagaY, GillGN (1998) Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. Proc Natl Acad Sci U S A 95: 11257–11262.
46. PondAC, BinX, BattsT, RoartyK, HilsenbeckS, et al. (2013) Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells 31: 178–189.
47. Montañez-WiscovichME, SeachristDD, LandisMD, VisvaderJ, AndersenB, et al. (2009) LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression. Oncogene 28: 3608–3618.
48. VisvaderJE, VenterD, HahmK, SantamariaM, SumEY, et al. (2001) The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proc Natl Acad Sci U S A 98: 14452–14457.
49. SmithBA, SheltonDN, KiefferC, MilashB, UsaryJ, et al. (2012) Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes. Genes Cancer 3: 550–563.
50. BourasT, PalB, VaillantF, HarburgG, Asselin-LabatML, et al. (2008) Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3: 429–441.
51. OakesSR, NaylorMJ, Asselin-LabatML, BlazekKD, Gardiner-GardenM, et al. (2008) The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 22: 581–586.
52. YamajiD, NaR, FeuermannY, PechholdS, ChenW, et al. (2009) Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. Genes Dev 23: 2382–2387.
53. KitajimaK, KawaguchiM, IacovinoM, KybaM, HaraT (2013) Molecular functions of the LIM-homeobox transcription factor Lhx2 in hematopoietic progenitor cells derived from mouse embryonic stem cells. Stem Cells 31: 2680–2689.
54. OstendorffHP, TursunB, CornilsK, SchlüterA, DrungA, et al. (2006) Dynamic expression of LIM cofactors in the developing mouse neural tube. Dev Dyn 235: 786–791.
55. FolguerasAR, GuoX, PasolliHA, StokesN, PolakL, et al. (2013) Architectural niche organization by LHX2 is linked to hair follicle stem cell function. Cell Stem Cell 13: 314–327.
56. MardaryevAN, MeierN, PoterlowiczK, SharovAA, SharovaTY, et al. (2011) Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development 138: 4843–4852.
57. Dey-GuhaI, MukhopadhyayM, PhillipsM, WestphalH (2009) Role of ldb1 in adult intestinal homeostasis. Int J Biol Sci 5: 686–694.
58. LiL, JothiR, CuiK, LeeJY, CohenT, et al. (2011) Nuclear adaptor Ldb1 regulates a transcriptional program essential for the maintenance of hematopoietic stem cells. Nat Immunol 12: 129–136.
59. HwangM, GorivodskyM, KimM, WestphalH, GeumD (2008) The neuronal differentiation potential of Ldb1-null mutant embryonic stem cells is dependent on extrinsic influences. Stem Cells 26: 1490–1495.
60. BachI, Rodriguez-EstebanC, CarrièreC, BhushanA, KronesA, et al. (1999) RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex. Nat Genet 22: 394–399.
61. OstendorffHP, PeiranoRI, PetersMA, SchlüterA, BossenzM, et al. (2002) Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors. Nature 416: 99–103.
62. BeckerT, OstendorffHP, BossenzM, SchlüterA, BeckerCG, et al. (2002) Multiple functions of LIM domain-binding CLIM/NLI/Ldb cofactors during zebrafish development. Mech Dev 117: 75–85.
63. LuP, SternlichtMD, WerbZ (2006) Comparative mechanisms of branching morphogenesis in diverse systems. J Mammary Gland Biol Neoplasia 11: 213–228.
64. MailleuxAA, Spencer-DeneB, DillonC, NdiayeD, Savona-BaronC, et al. (2002) Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. Development 129: 53–60.
65. KimS, DubrovskaA, SalamoneRJ, WalkerJR, GrandinettiKB, et al. (2013) FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells. PLoS One 8: e51671.
66. WagnerKU, McAllisterK, WardT, DavisB, WisemanR, et al. (2001) Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res 10: 545–553.
67. HerschkowitzJI, SiminK, WeigmanVJ, MikaelianI, UsaryJ, et al. (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8: R76.
68. MaglioneJE, MoghanakiD, YoungLJ, MannerCK, ElliesLG, et al. (2001) Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res 61: 8298–8305.
69. PandeyPR, SaidouJ, WatabeK (2010) Role of myoepithelial cells in breast tumor progression. Front Biosci (Landmark Ed) 15: 226–236.
70. DicksonC, Spencer-DeneB, DillonC, FantlV (2000) Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors. Breast Cancer Res 2: 191–196.
71. AdnaneJ, GaudrayP, DionneCA, CrumleyG, JayeM, et al. (1991) BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6: 659–663.
72. SunS, JiangY, ZhangG, SongH, ZhangX, et al. (2012) Increased expression of fibroblastic growth factor receptor 2 is correlated with poor prognosis in patients with breast cancer. J Surg Oncol 105: 773–779.
73. HunterDJ, KraftP, JacobsKB, CoxDG, YeagerM, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870–874.